Signaling Pathways
-
A8310 PF-5622711 CitationTarget: FAK|Pyk2Summary: ATP-competitive FAK inhibitor, reversible
-
A8311 Maraviroc2 CitationTarget: CCRSummary: Selective CCR5 antagonist,antiretroviral agent
-
A8312 Torin 17 CitationTarget: mTORSummary: MTOR inhibitor,potent and selective
-
A8315 NU7441 (KU-57788)4 CitationTarget: PI3K|DNA-PKSummary: DNA-PK inhibitor
-
A8316 PD 0332991 (Palbociclib) HCl5 CitationTarget: Cyclin-Dependent KinasesSummary: CDK4/6 inhibitor,highly selective
-
A8318 PP242Target: mTORSummary: MTOR inhibitor, selective and ATP-competitive
-
A8320 PF-00562271Target: FAK|Pyk2Summary: FAK/Pyk2 inhibitor,potent and ATP-competitive
-
A8324 LDN-193189Target: BMP and Other Activin ReceptorsSummary: ALK inhibitor,potent and selective
-
A8325 Tivantinib (ARQ 197)2 CitationTarget: METSummary: C-Met inhibitor,non-ATP-competitive
-
A8327 VerteporfinTarget: YAPSummary: Photosensitizer used in photodynamic therapy